Search - tctmd.com

Displaying 381 - 400 of 479

Sort: Relevancy | Date

Presentation TCT 2012

ISAR-DESIRE 3: A Prospective, Randomized Trial of Paclitaxel-Eluting Balloons vs. Paclitaxel-Eluting Stents vs. Balloon Angioplasty for Restenosis of Limus-Eluting Coronary Stents

Presenter: Robert Byrne

October 26, 2012

Presentation TCT 2012

SEDUCE: A Prospective, Randomized Trial of Drug Coated Balloon vs. Everolimus-Eluting Stent in for BMS Restenosis: Optical Coherence Tomography Assessment

Presenter: Tom Adriaenssens

October 25, 2012

Presentation TCT 2012

First-in-Man Results with a Novel Nanoparticle-Based Sirolimus-Coated Balloon in Coronary In-Stent Restenosis Lesions (Concept Medical)

Presenter: Suhas Lele

October 25, 2012

Presentation TCT 2012

Evaluation and Treatment of In-Stent Restenosis

Presenter: Christoph Kaiser

October 25, 2012

Presentation TCT 2012

In-Stent Restenosis: Mechanisms, Predictors, and Treatment

Presenter: Roxana Mehran

October 23, 2012

Presentation TCT 2012

DES Restenosis: Treatment Options and Recurrent Event Rates

Presenter: Alaide Chieffo

October 22, 2012

Presentation TCT 2012

Case Presentation (with Discussion): Recurrent DES Restenosis

Presenter: Simon Walsh

October 22, 2012

News Daily News

Los Balones liberadores de Fármacos arrojan Resultados Positivos en el Tratamiento de la Reestenosis intra stent

Jason Kahn

October 05, 2012

News Daily News

Drug-eluting Balloons Show Positive Results in Treating In-stent Restenosis

Jason Kahn

October 05, 2012

Presentation

Drug-eluting Balloon for Treatment of Superficial Femoral Artery In-stent Restenosis

Presenter: E. Stabile

October 04, 2012

News Daily News

Stent Fractures Persist Among Newer-Generation Devices

Jason Kahn

October 02, 2012

News Conference News ESC 2012

OCTOPUS Looks at Vessel Healing After DES vs. BMS Plus Paclitaxel Balloon

Caitlin E. Cox

August 29, 2012

News Daily News

Study Suggests Shortening Delay to Noncardiac Surgery After PCI

Yael L. Maxwell

August 17, 2012

News Industry News

Cardionovum® expects to launch next-generation product: drug-eluting coronary stent system, PROLIMUS Biograde

August 08, 2012

News Daily News

Meta-analysis: Paclitaxel-Coated Balloon Reduces TLR in Femoropopliteal Disease

August 07, 2012

News Daily News

RESET Published: Comparable Efficacy, Safety with EES, SES at 1 Year

L.A. McKeown

July 30, 2012

News Daily News

Xience V Noninferior to Cypher for Primary PCI

July 24, 2012

News Daily News

Reducir el Uso de SLF a la Mitad en Pacientes de Bajo Riesgo podría suponer un Ahorro de 200 millones de Dólares al Año

Yael L. Maxwell

July 11, 2012

News Daily News

Halving DES Use in Low-Risk Patients Could Save $200 Million Annually

Yael L. Maxwell

July 11, 2012

News Daily News

DES Show More Neoatherosclerosis Than BMS Over 4 Years

L.A. McKeown

July 05, 2012

Advertisement

ISAR-DESIRE 3: A Prospective, Randomized Trial of Paclitaxel-Eluting Balloons vs. Paclitaxel-Eluting Stents vs. Balloon Angioplasty for Restenosis of Limus-Eluting Coronary Stents

SEDUCE: A Prospective, Randomized Trial of Drug Coated Balloon vs. Everolimus-Eluting Stent in for BMS Restenosis: Optical Coherence Tomography Assessment

First-in-Man Results with a Novel Nanoparticle-Based Sirolimus-Coated Balloon in Coronary In-Stent Restenosis Lesions (Concept Medical)

Evaluation and Treatment of In-Stent Restenosis

In-Stent Restenosis: Mechanisms, Predictors, and Treatment

DES Restenosis: Treatment Options and Recurrent Event Rates

Case Presentation (with Discussion): Recurrent DES Restenosis

Los Balones liberadores de Fármacos arrojan Resultados Positivos en el Tratamiento de la Reestenosis intra stent

Drug-eluting Balloons Show Positive Results in Treating In-stent Restenosis

Drug-eluting Balloon for Treatment of Superficial Femoral Artery In-stent Restenosis

Stent Fractures Persist Among Newer-Generation Devices

OCTOPUS Looks at Vessel Healing After DES vs. BMS Plus Paclitaxel Balloon

Study Suggests Shortening Delay to Noncardiac Surgery After PCI

Cardionovum® expects to launch next-generation product: drug-eluting coronary stent system, PROLIMUS Biograde

Meta-analysis: Paclitaxel-Coated Balloon Reduces TLR in Femoropopliteal Disease

RESET Published: Comparable Efficacy, Safety with EES, SES at 1 Year

Xience V Noninferior to Cypher for Primary PCI

Reducir el Uso de SLF a la Mitad en Pacientes de Bajo Riesgo podría suponer un Ahorro de 200 millones de Dólares al Año

Halving DES Use in Low-Risk Patients Could Save $200 Million Annually

DES Show More Neoatherosclerosis Than BMS Over 4 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content